Recursion Pharmaceuticals, Inc. (RXRX)

3.63 +0.19 (+5.52%) USD  |  NASDAQ  |  Sep 04, 16:00
3.645 +0.02 (+0.41%) After-Hours: 20:00
More

Recursion Pharmaceuticals Cash and Short Term Investments (Annual) : 747.89M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 747.89M
December 31, 2024 597.40M
December 31, 2023 394.80M
December 31, 2022 551.19M
Date Value
December 31, 2021 518.11M
December 31, 2020 267.17M
December 31, 2019 75.17M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Twist Bioscience Corp. 232.43M
Absci Corp. 144.29M
Novavax, Inc. 745.96M
Editas Medicine, Inc. 146.64M
Halozyme Therapeutics, Inc. 142.82M